Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Cancer Lett. 2014 Apr 24;350(0):25–33. doi: 10.1016/j.canlet.2014.04.016

Table 1.

Treatment schedule of the immune-deficient, female NCr nude homozygous mice

Treatment group Dosage in mg/kg (administration) Frequency
Control saline (s.c.) daily
S-NACH 20 (s.c.) daily
Tinzaparin 5 (s.c.) daily
Gemcitabine 100 (i.p.) twice a week
S-NACH + gemcitabine 20 (s.c.) (S-NACH) daily
100 (i.p.) (gemcitabine) twice a week
Tinzaparin + gemcitabine 5 (s.c.) (tinzaparin) daily
100 (i.p.) (gemcitabine) twice a week

s.c. = subcutaneously; i.p. = intraperitoneally